Literature DB >> 15639402

Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.

Deepa Soni1, James A J King, Andrew H Kaye, Christopher M Hovens.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15639402     DOI： 10.1016/j.jocn.2004.04.001

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN： 0967-5868            Impact factor:   1.961


× No keyword cloud information.
  14 in total

1.  Proteasome inhibitor MG132 induces selective apoptosis in glioblastoma cells through inhibition of PI3K/Akt and NFkappaB pathways, mitochondrial dysfunction, and activation of p38-JNK1/2 signaling.

Authors:  Alfeu Zanotto-Filho; Elizandra Braganhol; Ana Maria Oliveira Battastini; José Cláudio Fonseca Moreira
Journal:  Invest New Drugs       Date:  2012-02-28       Impact factor: 3.850

2.  Gefitinib induces apoptosis in human glioma cells by targeting Bad phosphorylation.

Authors:  Cheng-Yi Chang; Chiung-Chyi Shen; Hong-Lin Su; Chun-Jung Chen
Journal:  J Neurooncol       Date:  2011-07-09       Impact factor: 4.130

Review 3.  The pathobiology of glioma tumors.

Authors:  Candece L Gladson; Richard A Prayson; Wei Michael Liu
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

4.  Genomic deletions correlate with underexpression of novel candidate genes at six loci in pediatric pilocytic astrocytoma.

Authors:  Nicola Potter; Aikaterini Karakoula; Kim P Phipps; William Harkness; Richard Hayward; Dominic N P Thompson; Thomas S Jacques; Brian Harding; David G T Thomas; Rodger W Palmer; Jeremy Rees; John Darling; Tracy J Warr
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

5.  Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells.

Authors:  Chunrong Yu; Bret B Friday; Lin Yang; Peter Atadja; Dennis Wigle; Jann Sarkaria; Alex A Adjei
Journal:  Neuro Oncol       Date:  2008-04-29       Impact factor: 12.300

6.  Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.

Authors:  Simona Daniele; Barbara Costa; Elisa Zappelli; Eleonora Da Pozzo; Simona Sestito; Giulia Nesi; Pietro Campiglia; Luciana Marinelli; Ettore Novellino; Simona Rapposelli; Claudia Martini
Journal:  Sci Rep       Date:  2015-04-21       Impact factor: 4.379

7.  Combination of unsaturated fatty acids and ionizing radiation on human glioma cells: cellular, biochemical and gene expression analysis.

Authors:  Otilia Antal; László Hackler; Junhui Shen; Imola Mán; Katalin Hideghéty; Klára Kitajka; László G Puskás
Journal:  Lipids Health Dis       Date:  2014-09-02       Impact factor: 3.876

Review 8.  Pharmacological Activities of Aminophenoxazinones.

Authors:  Jesús G Zorrilla; Carlos Rial; Daniel Cabrera; José M G Molinillo; Rosa M Varela; Francisco A Macías
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411

9.  Xyloketal B suppresses glioblastoma cell proliferation and migration in vitro through inhibiting TRPM7-regulated PI3K/Akt and MEK/ERK signaling pathways.

Authors:  Wen-Liang Chen; Ekaterina Turlova; Christopher L F Sun; Ji-Sun Kim; Sammen Huang; Xiao Zhong; Yong-Yuan Guan; Guan-Lei Wang; James T Rutka; Zhong-Ping Feng; Hong-Shuo Sun
Journal:  Mar Drugs       Date:  2015-04-22       Impact factor: 5.118

10.  Differential expression of microRNAs as predictors of glioblastoma phenotypes.

Authors:  Barrie S Bradley; Joseph C Loftus; Clinton J Mielke; Valentin Dinu
Journal:  BMC Bioinformatics       Date:  2014-01-18       Impact factor: 3.169
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.